Veradigm Inc. (MDRX)

Veradigm Inc. (MDRX) Discusses Strategic Reset, Product Portfolio Decisions and Growth Initiatives Transcript

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said.

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm's FollowMyHealth pat.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company's existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Right.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices. Independent practices continue to face rising administrative complexity and financial pressure, driven by den.

Veradigm Inc. (NASDAQ: MDRX - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $4.55, but opened at $4.70. Veradigm shares last traded at $4.70, with a volume of 567 shares changing hands. Veradigm Stock Up 1.1% The company's fifty day moving average price is $4.78 and its

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm's commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care. Since its launch last year, Veradigm Ambient Scribe has developed into a robus.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and int.

Veradigm Inc. - Special Call Company Participants Jenny Gelinas - Vice President of Investor Relations Leland Westerfield - Interim Chief Financial Officer Donald Trigg - Chief Executive Officer & Director Conference Call Participants Jeffrey Garro - Stephens Inc., Research Division Presentation Operator Greetings, and welcome to the Veradigm Investor Update Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing estimated financial performance for the second quarter of 2025 compared to the prior year, details about its recent financing activities, and reaffirmation of its outlook for the 2025 fiscal year. On Tuesday, September 2, longtime healthcare IT industry veteran Donald Trigg joined Veradigm as Chief Executive Officer and member of the Board of Directors. “The near-ter.

NEWTOWN, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Veradigm LLC.

Veradigm offers a sticky revenue healthcare IT business with a stable provider base and growing data segment, despite recent turmoil. It trades at distressed valuation levels due to accounting restatements, delisting from NASDAQ, and failed M&A, but fundamentals remain intact with net cash and flat revenues. Key catalysts include completion of restatements, NASDAQ relisting in 2026, and renewed strategic interest from private equity or industry consolidators.

PITTSBURGH, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Veradigm LLC (“Veradigm”), a health information technology company,1 recently announced a cybersecurity incident, which impacted the personal information of tens of thousands of individuals. In the incident, a cybercriminal hacker may have accessed records with personally identifiable information (“PII”) including name, contact details, date of birth, health records (such as diagnoses, medications, test results, and treatments), health insurance information, payment details, Social Security numbers, and driver's license numbers.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCEM: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on September 30th, 2025. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on October 1st, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the “Rights Plan”). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration.